Feedback / Questions
Elayta (zervimesine) - Cognition Therap
https://www.globenewswire.com/news-release/2025/08/12/3132086/0/en/Cognition-Therapeutics-Receives-End-of-Phase-2-Meeting-Minutes-Confirming-Alignment-with-U-S-FDA-on-Registrational-Path-for-Zervimesine-CT1812-in-Alzheimer-s-Disease.html
Aug 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next